Amazon S3 on MSN
Type 90 / The most expensive serial main battle tank in the 90s
Patreon: <a href="https://www.patreon.com/ArmyEncyclopedia">https://www.patreon.com/ArmyEncyclopedia</a> Donation: <a ...
The FDA has approved a device that aims to treat depression by sending electric current into a part of the brain known to ...
TDK Corporation introduces the new S series inrush current limiters (ICLs), comprising the S30 (ordering code: B57130S0*M000) ...
MedPage Today on MSN
For Your Patients: What to Know About the Newest Treatments for HR+/HER2- Breast Cancer
Resistance to initial therapy sets the stage for many other options ...
Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...
10hon MSN
Preoperative radiation may improve antitumor immune response in most common form of breast cancer
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when administered in combination with pembrolizumab (Keytruda) ...
Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.
T-DXd regimens improved pathologic complete response and safety profiles compared to ddAC-THP in high-risk, HER2-positive early breast cancer. Patient-reported outcomes showed better physical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback